AKT1 and cancer: Genetic silencing through transfection with siRNA of EGFR or ICAM-1 and pretreatment with inhibitors of EGFR, PI3K, Akt, NF-κB and IKK abrogated the AREG-enhanced ICAM-1 expression and cancer cell migration.